美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
69844-025-01	69844-025	HUMAN PRESCRIPTION DRUG	ranolazine	extended-release	TABLET	ORAL	20210128	N/A	ANDA	ANDA212889	Graviti Pharmaceuticals Private Limited	RANOLAZINE	1000 mg/1	30 TABLET in 1 BOTTLE (69844-025-01)
69844-025-02	69844-025	HUMAN PRESCRIPTION DRUG	ranolazine	extended-release	TABLET	ORAL	20210128	N/A	ANDA	ANDA212889	Graviti Pharmaceuticals Private Limited	RANOLAZINE	1000 mg/1	60 TABLET in 1 BOTTLE (69844-025-02)
69844-025-03	69844-025	HUMAN PRESCRIPTION DRUG	ranolazine	extended-release	TABLET	ORAL	20210128	N/A	ANDA	ANDA212889	Graviti Pharmaceuticals Private Limited	RANOLAZINE	1000 mg/1	500 TABLET in 1 BOTTLE (69844-025-03)
69844-024-03	69844-024	HUMAN PRESCRIPTION DRUG	ranolazine	extended-release	TABLET	ORAL	20210128	N/A	ANDA	ANDA212889	Graviti Pharmaceuticals Private Limited	RANOLAZINE	500 mg/1	500 TABLET in 1 BOTTLE (69844-024-03)
69844-024-02	69844-024	HUMAN PRESCRIPTION DRUG	ranolazine	extended-release	TABLET	ORAL	20210128	N/A	ANDA	ANDA212889	Graviti Pharmaceuticals Private Limited	RANOLAZINE	500 mg/1	60 TABLET in 1 BOTTLE (69844-024-02)
69844-024-01	69844-024	HUMAN PRESCRIPTION DRUG	ranolazine	extended-release	TABLET	ORAL	20210128	N/A	ANDA	ANDA212889	Graviti Pharmaceuticals Private Limited	RANOLAZINE	500 mg/1	30 TABLET in 1 BOTTLE (69844-024-01)